Comparison of the effects of chronic central administration and chronic peripheral administration of islet amyloid polypeptide on food intake and meal pattern in the rat.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Peptides

• Publication date

  2007-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.PEPTIDES.2007.06.011PMID 17614161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures

  2006cited by this paper
• PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice.

  2006cited by this paper
• PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity.

  2006cited by this paper
• Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats.

  2006cited by this paper
• Chronically Administered Islet Amyloid Polypeptide in Rats Serves as an Adiposity Inhibitor and Regulates Energy Homeostasis

  2005cited by this paper
• The effect of the melanocortin agonist, MT-II, on the defended level of body adiposity.

  2005cited by this paper
• Pancreatic amylin as a centrally acting satiating hormone.

  2005cited by this paper
• Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats.

  2004cited by this paper
• Amylin receptor blockade stimulates food intake in rats.

  2004cited by this paper
• The function of leptin in nutrition, weight, and physiology.

  2002cited by this paper
• Adrenomedullin and the Blood-Brain Barrier

  2001cited by this paper
• Inhibition of central amylin signaling increases food intake and body adiposity in rats.

  2001cited by this paper
• Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats.

  2001cited by this paper
• Amylin infusion into rat nucleus accumbens potently depresses motor activity and ingestive behavior.

  2001cited by this paper
• The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats

  2001cited by this paper
• Is parental control over children's eating associated with childhood obesity? Results from a population-based sample of third graders.

  2001cited by this paper
• Amylin receptors mediate the anorectic action of salmon calcitonin (sCT).

  2000cited by this paper
• Amylin: a novel action in the brain to reduce body weight.

  2000cited by this paper
• Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker rats.

  2000cited by this paper
• An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3.

  1999cited by this paper
• An Amylin Receptor Is Revealed Following Co-Transfection of a Calcitonin Receptor with Receptor Activity Modifying Proteins-1 or -3.

  1999cited by this paper
• Lesion of the area postrema/nucleus of the solitary tract (AP/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats.

  1998cited by this paper
• Anorectic effect of amylin is not transmitted by capsaicin-sensitive nerve fibers.

  1998cited by this paper
• Sufficiency of postprandial plasma levels of islet amyloid polypeptide for suppression of feeding in rats.

  1998cited by this paper
• Amylin reduces food intake more potently than calcitonin gene-related peptide (CGRP) when injected into the lateral brain ventricle in rats.

  1998cited by this paper
• Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats.

  1998cited by this paper
• Anorectic effect of amylin is not transmitted by capsaicin-sensitive nerve fibers.

  1998cited by this paper
• Turning off the signal: mechanisms that attenuate signaling by G protein-coupled receptors.

  1997cited by this paper
• Causes and Problems of Nonresponse or Poor Response to Drugs

  1996cited by this paper
• Chronic infusion of islet amyloid polypeptide causes anorexia in rats.

  1996cited by this paper
• Physiological mechanisms of cholecystokinin action on pancreatic secretion.

  1996cited by this paper
• Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake.

  1996cited by this paper
• Amylin given by central or peripheral routes decreases gastric emptying and intestinal transit in the rat

  1996cited by this paper
• Permeability of the blood-brain barrier to amylin.

  1995cited by this paper
• Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin.

  1995cited by this paper
• Reduction of food intake in rats by intraperitoneal injection of low doses of amylin.

  1994cited by this paper
• In vitro autoradiographic localization of amylin binding sites in rat brain.

  1994cited by this paper
• Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease.

  1994cited by this paper
• Anorexia following the systemic injection of amylin.

  1993cited by this paper
• High affinity amylin binding sites in rat brain.

  1993cited by this paper
• Molecular identification of binding sites for calcitonin gene-related peptide (CGRP) and islet amyloid polypeptide (IAPP) in mammalian lung: species variation and binding of truncated CGRP and IAPP.

  1993cited by this paper
• Investigation and characterization of binding sites for islet amyloid polypeptide in rat membranes.

  1992cited by this paper
• Anorexia following the intrahypothalamic administration of amylin.

  1991cited by this paper
• Effects of Meal Ingestion on Plasma Amylin Concentration in NIDDM and Nondiabetic Humans

  1990cited by this paper
• Effect of continuous infusions of CCK-8 on food intake and body and pancreatic weights in rats.

  1988cited by this paper
• A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas.

  1986cited by this paper
• Printed in U.S.A. Copyright © 1998 by The Endocrine Society Purification of Calcitonin-Like Peptides from Rat Brain and Pituitary*

  year unknowncited by this paper

• GLP‐1R biased cAMP agonism maintains glycemic control with reduced malaise and emesis in preclinical mammalian models

  2026cites this paper
• Role of amylin in feeding and satiation.

  2025cites this paper
• Chronic pramlintide decreases feeding via a reduction in meal size in male rats.

  2024cites this paper
• Neuroprotective Mechanisms of Amylin Receptor Activation, Not Antagonism, in the APP/PS1 Mouse Model of Alzheimer’s Disease

  2023cites this paper
• Amylin Pharmacology in Alzheimer’s Disease Pathogenesis and Treatment

  2021cites this paper
• Oral Amylin Treatment Reduces the Pathological Cascade of Alzheimer’s Disease in a Mouse Model

  2021cites this paper
• Systemic and Central Amylin, Amylin Receptor Signaling, and Their Physiological and Pathophysiological Roles in Metabolism.

  2020cites this paper
• High-Speed Atomic Force Microscopy Reveals the Structural Dynamics of the Amyloid-β and Amylin Aggregation Pathways

  2020cites this paper
• Association of Plasma Amylin Concentration With Alzheimer Disease and Brain Structure in Older Adults

  2019cites this paper
• Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer’s Disease

  2018cites this paper
• Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential

  2018cites this paper
• Neuroprotective Effects of Amylin Analogues on Alzheimer’s Disease Pathogenesis and Cognition

  2018cites this paper
• Amylin and its G-protein-coupled receptor: A probable pathological process and drug target for Alzheimer's disease.

  2017cites this paper
• An amylin analog used as a challenge test for Alzheimer's disease

  2017influential citation
• Amylin Enhances Amyloid-β Peptide Brain to Blood Efflux Across the Blood-Brain Barrier

  2017cites this paper
• Amylin in Alzheimer's disease: Pathological peptide or potential treatment?

  2017cites this paper
• Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease

  2017cites this paper
• Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer’s Disease Mouse Model

  2016cites this paper
• Increased female autosomal burden of rare copy number variants in human populations and in autism families

  2015cites this paper
• Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?

  2014cites this paper
• Association between Amylin and Amyloid-β Peptides in Plasma in the Context of Apolipoprotein E4 Allele

  2014influential citation
• Development of a neuromedin U–human serum albumin conjugate as a long‐acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide

  2014cites this paper
• Plasma Amylin and Cognition in Diabetes in the Absence and the Presence of Insulin Treatment

  2014cites this paper
• Positive Association between Plasma Amylin and Cognition in a Homebound Elderly Population

  2014cites this paper
• Insulin secretion, body composition and pig performance are altered by feeding pattern

  2014cites this paper
• Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease

  2014cites this paper
• PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes.

  2012cites this paper
• Food intake and meal pattern in IAPP knockout mice with and without infusion of exogenous IAPP

  2012cites this paper
• Steve Woods's contribution to research on amylin's eating inhibitory effect.

  2011cites this paper
• Effects of peripherally administered neuromedin U on energy and glucose homeostasis.

  2011cites this paper
• Influence of high-fat feeding, diet-induced obesity, and hyperamylinemia on the sensitivity to acute amylin.

  2011cites this paper
• Amylin sensitivity and secretion following diet-induced obesity in rats

  2010cites this paper
• The threshold of amylin-induced anorexia is lower in chicks selected for low compared to high juvenile body weight.

  2010cites this paper
• Central amylin acts as an adiposity signal to control body weight and energy expenditure.

  2010cites this paper
• Amylin suppresses acetic acid-induced visceral pain and spinal c-fos expression in the mouse.

  2010cites this paper
• Neuroendocrine and physiological regulation of intake with particular reference to domesticated ruminant animals

  2008cites this paper
• Central and peripheral administration of amylin induces energy expenditure in anesthetized rats.

  2008cites this paper
• Salmon calcitonin reduces food intake through changes in meal sizes in male rhesus monkeys.

  2008cites this paper
• Effects of different intermittent peptide YY (3-36) dosing strategies on food intake, body weight, and adiposity in diet-induced obese rats.

  2008cites this paper